Fernwood Investment Management, LLC - BRIDGEBIO PHARMA INC ownership

BRIDGEBIO PHARMA INC's ticker is BBIO and the CUSIP is 10806X102. A total of 169 filers reported holding BRIDGEBIO PHARMA INC in Q4 2020. The put-call ratio across all filers is 0.33 and the average weighting 0.7%.

Quarter-by-quarter ownership
Fernwood Investment Management, LLC ownership history of BRIDGEBIO PHARMA INC
ValueSharesWeighting
Q3 2023$6,213,299
+50.6%
235,620
-1.8%
2.23%
+52.6%
Q2 2023$4,126,194
+5.0%
239,895
+1.2%
1.46%
-3.0%
Q1 2023$3,929,046
+154.0%
236,975
+16.7%
1.51%
+135.6%
Q4 2022$1,546,860
-23.9%
203,000
-0.8%
0.64%
-25.3%
Q3 2022$2,033,000
+21.7%
204,550
+11.2%
0.86%
+19.0%
Q2 2022$1,670,000
-4.5%
183,900
+6.7%
0.72%
+17.3%
Q1 2022$1,749,000
-35.8%
172,325
+5.5%
0.61%
-31.2%
Q4 2021$2,726,000
-63.2%
163,400
+3.5%
0.89%
-64.9%
Q3 2021$7,401,000
-21.0%
157,898
+2.8%
2.54%
-17.9%
Q2 2021$9,368,000
+0.7%
153,672
+1.7%
3.10%
-9.5%
Q1 2021$9,307,000
-13.2%
151,085
+0.2%
3.42%
-19.0%
Q4 2020$10,726,000
+98.7%
150,835
+4.9%
4.23%
+65.8%
Q3 2020$5,397,000
+14.1%
143,835
-0.9%
2.55%
+9.0%
Q2 2020$4,732,000
+58.0%
145,100
+40.5%
2.34%
+22.3%
Q1 2020$2,994,000
-18.2%
103,250
-1.1%
1.91%
+9.3%
Q4 2019$3,659,000
+79.0%
104,400
+9.7%
1.75%
+72.8%
Q3 2019$2,044,00095,2001.01%
Other shareholders
BRIDGEBIO PHARMA INC shareholders Q4 2020
NameSharesValueWeighting ↓
Aisling Capital Management LP 6,068,125$55,099,00039.31%
M28 Capital Management LP 466,200$4,233,0004.74%
Kohlberg Kravis Roberts & Co. L.P. 31,060,971$282,034,0003.75%
Octagon Capital Advisors LP 933,743$8,478,0002.26%
VIKING GLOBAL INVESTORS LP 26,620,991$241,719,0001.11%
HHLR ADVISORS, LTD. 5,362,014$48,687,0001.04%
Cormorant Asset Management, LP 1,469,179$13,340,0001.01%
Knott David M Jr 213,206$1,936,0000.81%
Fernwood Investment Management, LLC 183,900$1,670,0000.72%
HighVista Strategies LLC 105,942$962,0000.58%
View complete list of BRIDGEBIO PHARMA INC shareholders